Matches in Wikidata for { <http://www.wikidata.org/entity/Q64680290> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64680290 description "clinical trial" @default.
- Q64680290 description "ensayu clínicu" @default.
- Q64680290 description "klinisch onderzoek" @default.
- Q64680290 description "клінічне випробування" @default.
- Q64680290 name "Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder" @default.
- Q64680290 type Item @default.
- Q64680290 label "Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder" @default.
- Q64680290 prefLabel "Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder" @default.
- Q64680290 P1132 Q64680290-513ADA65-6F63-474F-982C-4123E13E0B3C @default.
- Q64680290 P1476 Q64680290-3B5497F1-41E5-425C-AB33-8BFAD0D04F58 @default.
- Q64680290 P17 Q64680290-91DE2DD6-1066-4085-8D28-9317FD765368 @default.
- Q64680290 P2899 Q64680290-97EF2C0C-28D7-4232-8630-51F5ED2F8EE7 @default.
- Q64680290 P3098 Q64680290-AF6549EB-571F-4FA9-9F44-B2A917F8D754 @default.
- Q64680290 P31 Q64680290-629B956A-FF01-44E7-9867-07F205939B76 @default.
- Q64680290 P4135 Q64680290-80789EB9-96C3-4524-BE00-9C9F31119F11 @default.
- Q64680290 P4844 Q64680290-6F5DEDA2-A66A-4A05-9CEB-08D1134CFA89 @default.
- Q64680290 P580 Q64680290-24171186-EF88-4A27-B638-09A2E9CE898F @default.
- Q64680290 P582 Q64680290-2EE010B0-3BF8-41DD-A6C4-ADFC37575F52 @default.
- Q64680290 P6099 Q64680290-44A61851-74D8-4D44-8590-5C99B4C930B7 @default.
- Q64680290 P6153 Q64680290-6ADF589B-2384-42D6-9744-59E696BF2378 @default.
- Q64680290 P6153 Q64680290-7853DEDE-6E1E-4C88-AC9C-AE46FC61EE32 @default.
- Q64680290 P6153 Q64680290-E0E80023-AE5E-44EF-8E76-876A917A7E16 @default.
- Q64680290 P6153 Q64680290-E354216F-1A78-4BE6-A3A0-F62CFEE48AE2 @default.
- Q64680290 P6153 Q64680290-EE2F437A-E32D-4A1F-BAB5-8CC23018D9BB @default.
- Q64680290 P6153 Q64680290-FA385B1B-3148-4A0E-B356-B1CE0703E37C @default.
- Q64680290 P8363 Q64680290-BABF7ED1-1B5B-4C27-A4D5-8AAB1833A8B2 @default.
- Q64680290 P1132 "+123" @default.
- Q64680290 P1476 "A Phase 4, Double-Blind, Multi-Center, Placebo-Controlled, Randomized Withdrawal, Safety and Efficacy Study of SPD489 in Adults Aged 18-55 With Attention-Deficit/Hyperactivity Disorder (ADHD)" @default.
- Q64680290 P17 Q30 @default.
- Q64680290 P2899 "+18" @default.
- Q64680290 P3098 "NCT00877487" @default.
- Q64680290 P31 Q30612 @default.
- Q64680290 P4135 "+55" @default.
- Q64680290 P4844 Q27289243 @default.
- Q64680290 P580 "2009-04-01T00:00:00Z" @default.
- Q64680290 P582 "2010-09-01T00:00:00Z" @default.
- Q64680290 P6099 Q42825046 @default.
- Q64680290 P6153 Q30269522 @default.
- Q64680290 P6153 Q30269691 @default.
- Q64680290 P6153 Q30269859 @default.
- Q64680290 P6153 Q30282378 @default.
- Q64680290 P6153 Q50037015 @default.
- Q64680290 P6153 Q50037383 @default.
- Q64680290 P8363 Q78089383 @default.